Home
Vivimed Labs Ltd Share Price History
Vivimed Labs Ltd
NSE : 31 Jul, 2023
4.95-0.1 (-1.0%)
Prev Close
5.0
Open Price
5.3
Bid Price (QTY)
-
Offer Price (QTY)
-
Volume
206352
Today's High / Low
5.3 / 4.8
52 WK High / Low
5.3 / 0.0
Market Price of Vivimed Labs Ltd
1M
1Y
3Y
5Y
Monitoring Vivimed Labs Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.
History Market Price
| Date | Price | Open | High | Low |
|---|
Returns Comparison
1W
1M
3M
6M
1Y
3Y
5Y
10Y
Growth Parameters
| Parameter |  2017 |
|---|---|
| Sales (Cr.) | NaN |
| Sales YoY Gr. | - |
| Adj EPS | 26.41 |
| YoY Gr. | - |
| Net Profit (Cr.) | 214 |
| BVPS | 85.93 |
Key Financial Parameters
| Parameter | 2015 |
|---|---|
| Return on Capital Emp. % | 10.38 |
| Op. Profit Mgn % | 16.66 |
| Net Profit Mgn % | 5.22 |
| Debt to Equity % | 1.71 |
Latest Shareholding
Promoters Holdings Over Time
About Vivimed Labs Ltd
- Vivimed Labs Limited was originally incorporated on September 22, 1988 as a private limited company in the name of Emgi Pharmaceuticals & Chemicals Pvt Ltd. On April 21, 1994, the company got converted into a public limited company and the name was changed to Emgi Pharmaceuticals & Chemicals Ltd and thereafter, the Company name was finally changed to Vivimed Labs Limited on April 22, 1997. The Company is engaged in manufacturing of Specialty Chemicals (mainly used in Personal Care and Cosmetic Industry), Pharmaceuticals, API's and Formulations.
- The company has strong presence in the areas of Health & Personal Care, Contract Research and Manufacturing.
- The company has four subsidiary companies, namely Creative Health Care Pvt Ltd, Vivimed Holdings Ltd (Hong Kong), Vivimed Labs Europe Ltd (UK) and Vivimed Labs USA Inc.
FAQs for Vivimed Labs Ltd Share Price History
What are the key events that typically impact Vivimed Labs Ltd's share price history?
Key events that impact Vivimed Labs Ltd’s share price history include quarterly earnings releases, product launches, leadership changes, economic policies, and geopolitical developments.
How do stock splits affect Vivimed Labs Ltd's share price history?
Stock splits reduce the nominal price of Vivimed Labs Ltd's shares by increasing the number of outstanding shares, which typically makes the stock more accessible to a broader range of investors. Although the total market value of the company remains unchanged after the split, the split can affect investor perception and liquidity, potentially influencing the share price in the longer term.
How do dividends impact the share price history of Vivimed Labs Ltd?
Dividends can influence Vivimed Labs Ltd's share price history by typically causing a temporary dip on the ex-dividend date, as the stock price often adjusts to reflect the dividend payout. Over time, the impact of dividends on the share price may be offset by the company's overall financial performance and market conditions.
How do corporate announcements affect Vivimed Labs Ltd’s share price history?
Corporate announcements such as mergers, acquisitions, or strategic shifts can lead to significant price changes. Any optimistic development news on Vivimed Labs Ltd generally boosts the company’s share price, whereas negative news can lead to a decline in share price.
How can I use technical analysis to understand Vivimed Labs Ltd’s share price history?
To understand Vivimed Labs Ltd’s share price history using technical analysis, examine charts for patterns such as trends, support, and resistance levels, and apply indicators like moving averages or Relative Strength Index (RSI) to gauge potential future movements. Analyze historical data to identify recurring trends and signals that might suggest how the share price could behave under similar conditions.
Popular Search
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
